Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs

Hepato-Gastroenterology

Volumn 52, Issue 64, 2005, Pages 1134-1138

  Chiba, Toshimi ^a   Sato, Kimihiko ^a   Endo, Masaki ^a   Ando, Tatsuya ^a   Inomata, Masaaki ^a   Orii, Seishi ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Non steroidal anti inflammatory drugs

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; DUODENUM ULCER; EPIGASTRIC PAIN; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; STOMACH ANTRUM; STOMACH ULCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ADMINISTRATION SCHEDULE; DUODENAL ULCER; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SEX FACTORS; STOMACH ULCER;

EID: 21744449293     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Collier DSTJ, Pain JA: Non-steroidal anti- inflammatory drugs and peptic ulcer perforation. Gut 1985; 26:359-363.
2. Laine L: Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin North Am 1991; 6:489-504.
3. Haynes DR, Whitehouse MW, Vernon-Roberts B: The effects of some anti-arthritic drugs and cytokines on the shape and function of rodent macrophages. Int J Exp Pathol 1990; 72:9-22.
4. Konturek JW, Dembinski A, Konturek SJ, Stachura J, Domschke W: Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gasroenterology 1998; 114:245-255.
5. Me W, Chipman JG, Robertson DI, Erikson RL, Simmons DL: Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal anti-inflammatory drugs. Drug Dev Res 1992; 25:249-265.
6. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS10, a phorbol seter tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266:12866-12872.
7. Nakamura T, Yakahi K, Kurosawa S, Tomono H, Yamamura S, Minagawa Y, Ebihara T, Ogiwara S, Iwabuchi H: NSAIDs-associated gastric mucosal injuries-their clinical problems. Clin Gastroenterol 1999; 14:403-418. (In Japanese with English abstract)
8. Shiokawa Y, Nobunaga M, Saito T, Asaki S, Ogawa N: Epidemiology study on upper gastrointestinal lesions induced by non-steroid anti-inflammatory drugs. Ryumachi 1991; 31:96-111. (In Japanese with English abstract)
9. Soll AH: Consensus conference. Medical treatment of peptic ulcer disease. JAMA 1996; 275:622-629.
10. Raskin JB: Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. Am J Med 1999; 106:3S-12S.
11. Gracia Rodriguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual NSAIDs. Lancet 1994; 343:769-772.
12. Skander MP, Ryan FP: Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. Br Med J 1988; 297:833-834.
13. Stevenson G: The distribution of gastric ulcers: double contrast barium meal and endoscopy findings. Clin Radiol 1977; 28:617-624.
14. Fuchigami Y, Tanita N, Nishimura S, Takahashi A, Kawagishi K, Sawada K, Inoue Y, Irie K, Narabayashi T: Upper gastrointestinal endoscopic findings in patients with rheumatoid arthritis. Gastroenterol Endosc 1986; 28:2297-2305. (In Japanese with English abstract)
15. Cryer B: Second-generation cyclooxygenase-2-specific inhibitors. Clin Perspectives in Gastroenterology 2002; 5:122-128.